×
Click if you use Pushtronex ® system (on-body infusor with prefilled cartridge) and need support
Approved Use

Repatha® is an injectable prescription medicine used:

  • in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of heart surgery. READ MORE
  • along with diet alone or together with other cholesterol-lowering medicines in adults with high blood cholesterol levels called primary hyperlipidemia (including a type of high cholesterol called heterozygous familial hypercholesterolemia [HeFH]) to reduce low-density lipoprotein (LDL) or bad cholesterol.
For adults with heart disease
Amgen® Support+ Logo

Amgen® Support Plus Text Message Reminder

  • Mobile Terms and Conditions (Short Code 95093)

    NOTICE: The Amgen® Support Plus mobile SMS program for Repatha® (evolocumab) is not intended to be a source of medical advice or care. Please contact your healthcare provider if you have any questions about your medical condition, diagnosis, treatment or care.

    Amgen’s Amgen® Support Plus Alerts mobile Short Message Service (SMS) program runs on the short code 95093. Amgen will not charge you to use this Service; however, your Wireless Service Provider may charge for sending and/or receiving messages and for airtime. Message and Data Rates May Apply.

    1. By opting into the Amgen® Support Plus program you consent to receive a maximum of 6 messages per month from mobile short code 95093.
    2. To enroll in Amgen® Support Plus alerts or receive subscription messages: Visit Repatha.com or call 1-844-737-2842. Provide the required information including your mobile phone number. You will receive a mobile opt-in request message from 95093. Follow the texting prompts to JOIN.
    3. Text HELP to 95093 for help, STOP to 95093 to cancel.

    This Service is available on the following carriers: AT&T, Verizon Wireless, Sprint, Virgin Mobile, Boost, T-Mobile, MetroPCS, U.S. Cellular, Cricket Wireless, Google Voice, nTelos, Alaska Communications Systems (ACS), bandwidth.com (includes Republic Wireless), Bluegrass Cellular, Boost-CDMA, C Spire Wireless (Cellular South), CableVision, Carolina West Wireless, CellCom, Cellular One of N.E. Arizona, Chariton Valley Cellular, Chat Mobility, Cleartalk (Flat Wireless), Copper Valley Telecom, DTC Wireless, Duet Wireless, East Kentucky Network (Appalachian Wireless), ECIT/Cellular One of East Central Illinois, GCI Communications, Illinois Valley Cellular, Inland Cellular, IWireless, Leaco Rural Telephone Cooperative, Limitless Mobile, Mid-Rivers Communications, Mobi PCS, MobileNation/SI Wireless, MTA Wireless/Matanuska Kenai, MTPCS Cellular One (Cellone Nation), Nemont US UMTS, Nex Tech Communications, Northwest Missouri Cellular, Panhandle Wireless, Pine Cellular, Pioneer Cellular, Plateau Wireless, Rural Independent Network Alliance (RINA), Sagebrush, SouthernLINC, SRT Communications, Thumb Cellular, TracFone, Union Telephone, United Wireless, Viaero Wireless, and West Central Wireless. T-Mobile is not liable for delayed or undelivered messages.

    For additional questions, please call 1-844-737-2842.

    Amgen Inc. (“Amgen”) reserves the right, in its sole discretion, to change, modify, add, or remove these Mobile Terms of Use (“Mobile Terms”) at any time. Amgen may in its discretion change or suspend the Service (defined below) at any time. If you are dissatisfied with the Service or the content received through the Service, your sole remedy is to discontinue use of the Service.

    By using the Service and accepting these terms, you also agree to Amgen’s standard Terms of Use, incorporated herein by reference. In the event of a conflict between the standard Terms of Use and these Mobile Terms, these Mobile Terms shall prevail. For Amgen privacy practices, please see our Privacy Policy. For the full Mobile Terms and Conditions related to this SMS program, please see our mobile terms and conditions page.

Important Safety Information

Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.

Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. The needle covers on the single-dose prefilled syringes and the inside of the needle caps on the single-dose prefilled SureClick® autoinjectors contain dry natural rubber. The single-dose Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex.

Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take.

What are the possible side effects of Repatha®?

Repatha® can cause serious side effects including serious allergic reactions. Stop taking Repatha® and call your healthcare provider or seek emergency help right away if you have any of these symptoms: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.

The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, high blood sugar levels (diabetes) and redness, pain, or bruising at the injection site.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

APPROVED USE

What is Repatha®?

Repatha® is an injectable prescription medicine used:

  • in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of heart surgery.
  • along with diet alone or together with other cholesterol-lowering medicines in adults with high blood cholesterol levels called primary hyperlipidemia (including a type of high cholesterol called heterozygous familial hypercholesterolemia [HeFH]) to reduce low density lipoprotein (LDL) or bad cholesterol.

Please see full Prescribing Information.